Your request goes to Bertis Inc.. Follow up with them in Messages on Global Trade Plaza.
Proteomics-based Early diagnosis using multiple markers provides a quick and accurate solution for early diagnosis of major diseases by utilizing multiple proteomic biomarker-based blood tests. Early diagnostic solutions BERTIS has commercialized MASTOCHECK, the worlds first proteomics-based blood test solution for early diagnosis of breast cancer, and clinical trials are being conducted on biomarkers for various cancers. Ultimately, these technologies are being used to continually expand the pipeline to allow dozens of diseases to be diagnosed with a single blood test.
Describe what you need once. Suppliers who deal in it see your requirement as a buy lead and can send you offers.
This multiple-marker test uses proteomics-based early diagnosis to screen for major diseases through blood tests that measure several proteomic biomarkers. The pipeline originates from MASTOCHECK, described as the world's first proteomics-based blood test for early breast cancer diagnosis.
Clinical trials are ongoing for biomarkers of various cancers, with the goal of expanding the panel to enable diagnosis of dozens of diseases from a single blood draw.
The seller has not added a specification yet; ask for the data sheet or test certificate. Ask Bertis Inc. for a firm quote and delivery terms before you order.
Bertis Inc. is a B2B supplier based in South Korea (Republic Of Korea), listed on Global Trade Plaza since October 2026. Use Inquire now or Chat with supplier to ask Bertis Inc. for prices, specifications and documents for Cancer Detection Multiple Markers Test.
Ask Bertis Inc. which payment terms they accept for Cancer Detection Multiple Markers Test. Agree the payment terms in writing with the supplier before you pay.
Placing an order for Cancer Detection Multiple Markers Test with Bertis Inc. is quick and straightforward on Global Trade Plaza, a leading B2B marketplace for global buyers and suppliers. You can:
When purchasing Cancer Detection Multiple Markers Test from a B2B marketplace in 2025, focus on the following critical factors:
Comparing prices and communicating directly with Bertis Inc. can help ensure value for money and better sourcing decisions.
Global Trade Plaza is home to B2B buyers, wholesalers, distributors, and importers of Cancer Detection Multiple Markers Test across industries and countries. To discover the most active and high-value buyers:
Bertis Inc., a B2B supplier from South Korea (Republic Of Korea), dispatches Cancer Detection Multiple Markers Test primarily through the port at South Korea (Republic Of Korea). Packaging types (e.g., bulk, custom, eco-friendly) and estimated pricing may vary based on order volume and destination. To get detailed logistics and pricing information, use Get a quote or Chat with supplier, or Sign Up for direct supplier interaction.